###begin article-title 0
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 0 16 <span type="species:ncbi:5476">Candida albicans</span>
Candida albicans induces cyclo-oxygenase 2 expression and prostaglandin E2 production in synovial fibroblasts through an extracellular-regulated kinase 1/2 dependent pathway
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 148 164 148 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 148 164 <span type="species:ncbi:5476">Candida albicans</span>
Synovial cells are potential sources of inflammatory mediators in bacterial-induced arthritis but their involvement in the inflammatory response to Candida albicans-induced septic arthritis is largely unknown.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 64 76 64 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 20 23 <span type="species:ncbi:10116">rat</span>
###xml 64 75 <span type="species:ncbi:5476">C. albicans</span>
Primary cultures of rat synovial fibroblasts were infected with C. albicans (ATCC90028). Immunocytochemistry, western blotting, and RT-PCR were performed to assess cyclo-oxygenase 2 induction. Phosphorylation of extracellular-regulated kinase (ERK1/2) following infection in the absence or presence of U0126 was assessed by western blotting whilst prostaglandin E2 production was measured by ELISA. Nuclear factor kappaB (NFkappaB) translocation was evaluated by an electrophoretic mobility shift assay.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 39 51 39 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 421 433 417 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 39 50 <span type="species:ncbi:5476">C. albicans</span>
###xml 421 432 <span type="species:ncbi:5476">C. albicans</span>
Infection of synovial fibroblasts with C. albicans resulted in cyclo-oxygenase 2 expression and prostaglandin E2 production. Cyclo-oxygenase 2 expression and prostaglandin E2 production was dependent upon extracellular-regulated kinase 1/2 phosphorylation, associated with activation of NFkappaB and significantly elevated in the presence of laminarin, an inhibitor of dectin-1 activity. Synovial fibroblasts adjacent to C. albicans hyphae aggregates appeared to be the major contributors to the increased levels of cyclo-oxygenase 2 and phosphorylated extracellular-regulated kinase 1/2.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 46 55 46 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 0 11 <span type="species:ncbi:5476">C. albicans</span>
C. albicans infection of synovial fibroblasts in vitro results in upregulation of cyclo-oxygenase 2 and prostaglandin E2 by mechanisms that may involve activation of extracellular-regulated kinase 1/2 and are associated with NFkappaB activation.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 310 327 310 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 600 612 600 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 752 764 752 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1092 1094 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 310 326 <span type="species:ncbi:5476">Candida albicans</span>
###xml 545 564 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 600 611 <span type="species:ncbi:5476">C. albicans</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 752 763 <span type="species:ncbi:5476">C. albicans</span>
Infectious arthritis is a potentially serious disease that may cause rapid destruction of the joint and produce permanent deformities. Articular structures can be affected by mycotic infections through direct inoculation, contiguous spread, or hematogenous dissemination [1-4]. Of the various Candida species, Candida albicans is most commonly associated with fungal arthritis, especially in immunocompromized individuals [4-7]. Typically infection predominates in large weight-bearing joints, most often the knee [8]. Experimental arthritis in Sprague-Dawley rats with intravenous administration of C. albicans demonstrates that Candida arthritis involves not only joint tissues but also adjacent bones [9]. In mice, direct inoculation of joints with C. albicans results in a rapidly progressive septic arthritis that also exacerbates collagen-induced arthritis [10]. Fungal infection may also induce and exacerbate autoimmune diseases such as rheumatoid arthritis potentially through effects of beta-glucans, polysaccharides in the cell wall of fungi, on inflammatory and immune responses [11].
###end p 11
###begin p 12
###xml 293 295 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 296 298 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 366 368 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 369 371 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 519 521 513 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 525 526 519 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 540 542 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 543 545 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 563 575 557 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 597 599 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 630 632 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 651 660 645 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 661 663 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 808 810 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 811 813 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 879 881 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 915 917 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 918 920 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 961 963 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 964 966 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1041 1043 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1044 1046 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1237 1239 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 563 574 <span type="species:ncbi:5476">C. albicans</span>
Cyclo-oxygenase 2 (COX-2) is a key enzyme involved in joint inflammation through production of prostaglandins. COX-2 is induced in human joint tissues, including chondrocytes and synoviocytes, by inflammatory stimuli such as interleukin 1beta (IL1beta), IL17, and tumor necrosis factor (TNF) [12-20] and has roles in cartilage degradation and synovial angiogenesis [16,21]. Micro-oganisms of all types, mostly bacterial infections, can produce an infectious arthritis associated with COX-2 induction and prostaglandin E2 (PGE2) production [22-24]. In response to C. albicans infection HeLa cells [25], vascular endothelial cells [26], and macrophages in vitro [27] have been shown to express COX-2. The signal transduction pathways resulting in COX-2 expression may involve Toll-like receptor (TLR) 2 and 4 [25,28], which activate a variety of signaling molecules including p38 [29], c-Jun N-terminal kinase (JNK) [29,30], extracellular-regulated kinase (ERK) [31,32], protein kinase C (PKC), and activated nuclear factor kappaB (NFkappaB) [25,30]. More recently dectin-1 the receptor for beta-glucan a fungal wall component has been shown to be involved in the induction of cytokines and chemokines possibly by collaborating with TLRs [33].
###end p 12
###begin p 13
###xml 36 48 36 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 293 305 293 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 315 323 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 36 47 <span type="species:ncbi:5476">C. albicans</span>
###xml 293 304 <span type="species:ncbi:5476">C. albicans</span>
Although it is well documented that C. albicans may induce joint inflammation and destruction, the detailed inflammatory responses and associated mechanisms are largely unknown. The present study was undertaken to establish a model to examine COX-2 induction in synovial fibroblasts following C. albicans infection in vitro.
###end p 13
###begin title 14
Materials and methods
###end title 14
###begin title 15
Synovial fibroblast isolation and culture
###end title 15
###begin p 16
###xml 1135 1137 1129 1131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1298 1300 1286 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 25 29 <span type="species:ncbi:10116">rats</span>
###xml 364 368 <span type="species:ncbi:10116">rats</span>
###xml 986 992 <span type="species:ncbi:9913">bovine</span>
Male Sprague-Dawley (SD) rats (8 weeks old, 280 to 300 g) were obtained from BioLASCO Taiwan (Taipei, Taiwan). All experiments were approved by the local Institutional Review Board and performed in adherence to the National Institutes of Health Guidelines for the treatment of laboratory animals. The synovium of knee joints was aseptically removed from normal SD rats, cut into small fragments and incubated with antimicrobial solution (500 IU/ml penicillin/streptomycin; Gibco Invitrogen, Burlington, Ontario, Canada) for 1 h, washed with sterile phosphate-buffered saline (PBS) before digestion with 3 mg/ml collagenase type H (Sigma, St Louis, MO, USA) at 37degreesC for 12 h. The resultant cell suspension was centrifuged at 2,500 rpm for 10 minutes following which the supernatant was discarded and the pellet resuspended in PBS. After further centrifugation at 1,000 rpm for 10 minutes, cells were resuspended and seeded in 20 ml of Ham's F12 medium (Sigma) containing 10% fetal bovine serum (Gibco Invitrogen) and 100 IU/ml penicillin/streptomycin (Gibco Invitrogen). The synovial cells were then cultured in a humidified 5% CO2 atmosphere at 37degreesC until confluent, detached with 0.05% trypsin/ethylenediaminetetraacetic acid (EDTA) (Gibco Invitrogen) and seeded at a density of 2 x 105 cells/dish in 60 mm tissue culture dishes (Orange scientific, Braine-l'Alleud, Belgium) for further experimental procedures.
###end p 16
###begin title 17
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 0 11 <span type="species:ncbi:5476">C. albicans</span>
C. albicans preparation
###end title 17
###begin p 18
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 236 238 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 247 249 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 0 11 <span type="species:ncbi:5476">C. albicans</span>
###xml 249 255 <span type="species:ncbi:4932">yeasts</span>
C. albicans (ATCC 90028) was grown on Sabouraud dextrose agar (BD Microbiology System, Sparks, MD, USA) at 25degreesC. After a 16-h culture, colonies were suspended in PBS (Gibco Invitrogen) and prepared to the desired density of 1 x 103 to 1 x 107 yeasts/ml.
###end p 18
###begin title 19
###xml 26 38 26 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 26 37 <span type="species:ncbi:5476">C. albicans</span>
Experimental protocol for C. albicans incubation with synovial fibroblasts
###end title 19
###begin p 20
###xml 146 158 144 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 165 167 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 176 178 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 199 201 197 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 871 883 854 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 969 981 952 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 146 157 <span type="species:ncbi:5476">C. albicans</span>
###xml 178 184 <span type="species:ncbi:4932">yeasts</span>
###xml 871 882 <span type="species:ncbi:5476">C. albicans</span>
###xml 969 980 <span type="species:ncbi:5476">C. albicans</span>
Dishes of synovial fibroblasts were placed in serum-free media (3 ml) overnight and then treated with either 200 muL PBS or 200 muL suspension of C. albicans (2 x 102 to 2 x 106 yeasts/dish) in 5% CO2 atmosphere at 37degreesC for 6 or 12 h. In some experiments synovial fibroblasts were pre-incubated with U0126 (Cell Signaling Technology, Beverly, MA, USA), a mitogen-activated protein kinase (MEK)1/2 inhibitor, at a concentration of 20 muM for 2 h; laminarin (Sigma) a beta-glucan receptor blocking agent and specific inhibitor of dectin-1 activity at a concentration of 10 mg/ml for 1 h. MG-132 (Calbiochem, San Diego, CA, USA) as a NFkappaB inhibitor was co-incubated with synovial fibroblasts at a concentration of 35 muM. For the trans-well experiments (Transwell, Corning Incorporated, Corning, NY, USA), synovial fibroblasts were seeded in the upper chamber and C. albicans were plated in the lower chamber overnight, and then interacted for 12 h. In controls C. albicans were omitted from the lower chamber.
###end p 20
###begin title 21
Immunocytochemistry
###end title 21
###begin p 22
###xml 52 63 52 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 52 63 <span type="species:ncbi:5476">C. albicans</span>
###xml 499 504 <span type="species:ncbi:9796">horse</span>
###xml 560 566 <span type="species:ncbi:9913">bovine</span>
###xml 938 949 <span type="species:ncbi:3704">horseradish</span>
After a 12-h co-culture of synovial fibroblasts and C. albicans, cells and fungi on dish were washed with ice-cold PBS twice and then fixed using 2 ml of a 1:1 methanol/acetone mixture per dish for 5 minutes at -20degreesC. Cells were then stained by immunocytochemistry. Immunodetection for COX-2 was performed with a standard avidin-biotin-peroxidase complex detection kit (DakoCytomation, Glostrup, Denmark). Dishes were washed twice with PBS and blocked by incubation with 200 muL 1% non-immune horse serum (Vector Laboratories, Burlingame, CA, USA) in 1% bovine serum albumin (BSA) in antibody diluent (DakoCytomation) for 30 minutes at room temperature. The solution was poured off and the cells incubated sequentially with anti-COX-2 epitope specific antibody (1:200) (Lab Vision Corporation, Cheshire, UK) or anti-phospho-ERK1/2 (1:100) (Cell Signaling) for 60 minutes, biotinylated secondary antibody (1:200) for 45 minutes, and horseradish peroxidase (HRP)-conjugated streptavidin for 20 minutes. Between each incubation cells were washed with Tris-buffered saline/Tween (TBST) (12.5 mM Tris/HCl, pH 7.6, 137 mM NaCl, 0.1% Tween 20) three times. The chromogen 3-amino-9-ethylcarbazole (AEC) was then added for 15 minutes and finally counterstained with Mayer's hematoxylin. The cells were mounted with a coverslip and visualized under light microscopy.
###end p 22
###begin title 23
Reverse transcription PCR
###end title 23
###begin p 24
###xml 86 98 86 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 326 329 323 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">14 </sub>
###xml 1611 1613 1564 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1782 1784 1735 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 86 97 <span type="species:ncbi:5476">C. albicans</span>
Total RNA was isolated from cells after a 12-h co-culture of synovial fibroblasts and C. albicans using easy-BLUE Total RNA Extraction Kit (iNtRON Biotechnology, Gyeonggi-do, Korea). For first strand cDNA synthesis, 3 mug of total RNA was used in a single-round RT reaction (total volume 20 mul), containing 0.75 mug oligo(dT)14 primer, 1 mM deoxynucleosides (dNTPs), 1 x first strand buffer, 0.4 mM dithiothreitol (DTT), 40 units RNaseOut recombinant ribonuclease inhibitor, and 200 units of superscript II reverse transcriptase (Gibco Invitrogen). The reverse transcription reaction was performed at 42degreesC for 2 h, followed by 95degreesC for 5 minutes. PCR was run using 0.9 mul of the reverse transcription reaction mixture as template, 0.4 mM of gene specific primers, 1 x PCR buffer, 0.25 mM dNTPs, and 1.5 units of Taq DNA polymerase (BioMan, Taipei, Taiwan). The amplification was carried out at 94degreesC for 1 minute, then for 30 cycles at 94degreesC for 1 minute, 56degreesC for 1 minute, and 72degreesC for 1 minute followed by a final extension at 72degreesC for 10 minutes. All PCR products were size-fractionated by a 1.5% agarose gel electrophoresis, and DNA bands were visualized by staining the gel with 0.1 mug/ml ethidium bromide. The bands were analyzed using gel documentation system (Bio-Profil, Bio-1D version 99; Viogene, Sunnyvale, CA, USA). The values were expressed as ratio of the band intensity of the target gene to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the ratio of the band intensity of COX-2/GAPDH in the control condition was normalized to 1. Variance and P values were analyzed by Alphaimager 1220 V5.5 (Alpha Innotech Corporation, San Leandro, CA, USA). A Student t test was used for statistical comparison between groups. A P value of less than 0.05 was considered statistically significant.
###end p 24
###begin p 25
The primers used were as follows: COX-2 5'-GTCTCTCATCTGCAATAATGTG-3' (sense) and 5'-ATCTGTGTGGGTACAAATTTG-3' (antisense) ([GenBank:]; PCR product 801 base pairs (bp)); GAPDH 5'-CCCATCACCATCTTCCAGGAG-3' (sense) and 5'-GTTGTCATGGATGACCTTGGCC-3' (antisense) ([GenBank:]; PCR product 284 bp).
###end p 25
###begin title 26
Analysis of COX-2, ERK1/2 and phospho-ERK1/2 expression
###end title 26
###begin p 27
###xml 10 22 10 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 110 111 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 113 115 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 133 141 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 249 250 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 252 253 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 10 21 <span type="species:ncbi:5476">C. albicans</span>
###xml 1421 1426 <span type="species:ncbi:10090">Mouse</span>
Following C. albicans infection cells for 12 h were immediately washed with ice-cold PBS containing 100 muM Na3VO4 (Sigma) and lysed in situ with ice-cold lysis buffer at 4degreesC for 15 minutes. Lysis buffer contained 1% Igepal (Sigma), 100 muM Na3VO4, and a protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany). Whole cell lysates were collected after centrifugation at 14,500 rpm for 15 minutes. Protein concentration was determined by the Lowry method. Equal amounts of protein (20 mug) were loaded onto 10% SDS polyacrylamide gels and were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore Immobilon-P, Sigma). Membranes were blocked overnight at 4degreesC with 2% BSA in TBST. After washing three times with TBST, blots were incubated for 1 h at room temperature with primary antibody (anti-COX-2, 1/1,000 dilution; anti-total ERK1/2, 1/2,000 dilution; anti-phospho-ERK1/2, 1/2,000 dilution) diluted with 2% BSA in TBST. After washing six times with TBST, the blots were then incubated with HRP-labeled secondary antibody (1/1,000 dilution) for 1 h at room temperature. Membranes were rewashed extensively and binding was detected using Enhanced Chemiluminescense western blotting detection system (Amersham Pharmacia Biotech, Piscataway, NJ, USA), according to the manufacturer's instructions. Anti-ERK1/2 and phospho-ERK1/2 antibodies were from Cell Signaling Technology. Mouse monoclonal antibody tubulin Ab-4 (primary antibody, 1/5,000 dilution; secondary antibody, 1/20,000 dilution) (Lab Vision) served as internal control. The band was semiquantified by densitometry using systems as described above.
###end p 27
###begin title 28
Activation of NFkappaB by electrophoretic-mobility shift assay (EMSA)
###end title 28
###begin p 29
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 33 45 33 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 33 44 <span type="species:ncbi:5476">C. albicans</span>
###xml 378 385 <span type="species:ncbi:28980">Redwood</span>
Cells were infected with 2 x 105 C. albicans at 37degreesC for 6 h. Nuclear and cytoplasmic extracts of synovial fibroblasts were prepared using NE-PER nuclear and cytoplasmic extraction reagents according to the manufacturer's protocols (Pierce, Rockford, IL, USA). A non-radioactive EMSA was performed using an EMSA kit according to the manufacturer's instructions (Panomics, Redwood City, CA, USA). Nuclear protein (8 mug) was used to bind biotinylated oligonucleotides containing the NFkappaB binding site for 30 minutes at room temperature. The blank control was nuclear extracts being replaced with water. A competition/cold control was set up by adding non-biotin-labeled cold probes to the reaction. Samples were separated in a non-denaturing polyacrylamide gel (6%, with 2.5% glycerol) and blotted on a Biodyne B Pre-cut Modified Nylon membrane (Pierce). The biotin was labeled with alkaline phosphatase-conjugated streptavidin and alkaline phosphatase was detected with Enhanced Chemiluminescense western blotting detection system (Amersham). The band was semiquantified by densitometry using systems as described above.
###end p 29
###begin title 30
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Measurement of PGE2, IL1beta, and TNFalpha production in culture medium
###end title 30
###begin p 31
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 33 45 33 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 184 185 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 33 44 <span type="species:ncbi:5476">C. albicans</span>
Cells were infected with 2 x 105 C. albicans in the presence or absence of U0126 (20 muM, pre-incubation for 2 h) at 37degreesC for 12 h. The culture supernatant was harvested, and PGE2, IL1beta, and TNFalpha concentrations were measured by ELISA (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 19 31 19 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 19 30 <span type="species:ncbi:5476">C. albicans</span>
COX-2 induction by C. albicans infection
###end title 33
###begin p 34
###xml 14 26 14 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 265 277 265 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 329 341 329 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 513 515 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 557 559 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 642 644 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 739 741 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 14 25 <span type="species:ncbi:5476">C. albicans</span>
###xml 265 276 <span type="species:ncbi:5476">C. albicans</span>
###xml 329 340 <span type="species:ncbi:5476">C. albicans</span>
###xml 515 521 <span type="species:ncbi:4932">yeasts</span>
###xml 617 622 <span type="species:ncbi:4932">yeast</span>
The effect of C. albicans on COX-2 expression by synovial fibroblasts was assessed at the molecular and protein level. Extraction of total RNA from synovial fibroblasts was performed after 12-h co-culture of synovial fibroblasts with different seeding densities of C. albicans and COX-2 induction examined by RT-PCR. Addition of C. albicans to synovial fibroblasts increased COX-2 expression in a dose dependent manner. A significant increase in COX-2 expression over basal conditions was seen at a dose of 2 x 104 yeasts/dish (2.03 +/- 0.74-fold increase, P = 0.0185) with no further increase when higher numbers of yeast were added (Figure 1a). The expression of COX-2 protein showed a similar pattern to that of mRNA expression (Figure 1b).
###end p 34
###begin p 35
###xml 61 78 61 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 241 252 241 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 254 258 254 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 722 724 720 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 733 737 731 735 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 838 850 836 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1107 1109 1103 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 61 77 <span type="species:ncbi:5476">Candida albicans</span>
###xml 241 252 <span type="species:ncbi:5476">C. albicans</span>
###xml 838 849 <span type="species:ncbi:5476">C. albicans</span>
Cyclo-oxygenase 2 (COX-2) expression following co-culture of Candida albicans with synovial fibroblasts. COX-2 expression by synovial fibroblasts was assessed after 12-h co-culture of synovial fibroblasts with different seeding densities of C. albicans. (a) Gene expression. A representative agarose gel demonstrating COX-2 mRNA expression as assessed by reverse transcription polymerase chain reaction (RT-PCR). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as internal control. The graph shows the results of densitometric analysis of DNA bands expressed as the mean +/- standard deviation (SD) of the relative fold change in COX-2/GAPDH ratio with the ratio of the control condition normalized to 1 (N = 6, * P < 0.05). (b) Protein expression. A representative western blot of COX-2 protein expression following infection by C. albicans with tubulin as an internal protein loading control. The graph shows the results of densitometric analysis of bands expressed as the mean +/- SD of the relative change in COX-2/tubulin ratio with the ratio of the control condition normalized to 1 (N = 5, * P < 0.05).
###end p 35
###begin p 36
###xml 174 186 174 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 174 185 <span type="species:ncbi:5476">C. albicans</span>
To ascertain whether COX-2 induction was mediated by production of a soluble mediator in the system culture medium was collected from co-cultures of synovial fibroblasts and C. albicans and added directly to non-infected synovial fibroblasts. No change in COX-2 expression was seen. The levels of IL1beta and TNFalpha production were also undetectable (data not shown).
###end p 36
###begin title 37
###xml 35 47 35 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 35 46 <span type="species:ncbi:5476">C. albicans</span>
ERK1/2 activation is necessary for C. albicans induction of COX-2 expression
###end title 37
###begin p 38
###xml 148 160 144 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 404 405 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 585 597 577 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 615 617 607 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 647 649 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 702 714 694 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 723 725 715 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 824 826 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 148 159 <span type="species:ncbi:5476">C. albicans</span>
###xml 585 596 <span type="species:ncbi:5476">C. albicans</span>
###xml 617 623 <span type="species:ncbi:4932">yeasts</span>
###xml 702 713 <span type="species:ncbi:5476">C. albicans</span>
###xml 725 731 <span type="species:ncbi:4932">yeasts</span>
COX-2 expression by proinflammatory cytokines is associated with ERK1/2 and NFkappaB activation. To establish if similar events were occurring with C. albicans infection of synovial fibroblasts a series of experiments were undertaken to identify whether either ERK1/2 or NFkappaB were activated under the experimental conditions that result in increased COX-2 expression. The results are shown in Figure 2. Co-incubation of synovial fibroblasts resulted in ERK1/2 activation in a dose dependent manner. Significant levels of ERK1/2 phosphorylation were identified with the addition of C. albicans at doses of 2 x 104 yeasts/dish and above (Figure 2a). Following co-culture of synovial fibroblasts with C. albicans at 2 x 105 yeasts/dish for 6 h, NFkappaB electrophoretic-mobility shift showed activation of NFkappaB (Figure 2b).
###end p 38
###begin p 39
###xml 140 156 132 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 158 162 150 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 211 223 203 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 402 406 394 398 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 454 466 446 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 742 744 722 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 140 156 <span type="species:ncbi:5476">Candida albicans</span>
###xml 211 222 <span type="species:ncbi:5476">C. albicans</span>
###xml 454 465 <span type="species:ncbi:5476">C. albicans</span>
Activation of extracellular-regulated kinase (ERK1/2) and nuclear factor kappaB (NFkappaB) following infection of synovial fibroblasts with Candida albicans. (a) Synovial fibroblasts were infected for 12 h with C. albicans and levels of total and phosphorylated ERK1/2 (P-ERK1/2) assessed. Tubulin served as protein loading control. Shown is a representative western blot from one of five experiments. (b) Synovial fibroblasts were infected for 6 h with C. albicans and NFkappaB activation assessed by electrophoretic-mobility shift assay (EMSA). Upper panel: NFkappaB EMSA. The first lane of the NFkappaB series is the blank control. The lower series is the cold control. Lower panel: semiquantitative analysis of EMSA band density (N = 3, *P < 0.05).
###end p 39
###begin p 40
###xml 203 215 202 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 222 224 221 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 254 256 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 259 271 258 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 519 521 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 553 554 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 648 660 643 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 701 713 696 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 203 214 <span type="species:ncbi:5476">C. albicans</span>
###xml 224 230 <span type="species:ncbi:4932">yeasts</span>
###xml 259 270 <span type="species:ncbi:5476">C. albicans</span>
###xml 648 659 <span type="species:ncbi:5476">C. albicans</span>
###xml 701 712 <span type="species:ncbi:5476">C. albicans</span>
We next examined whether COX-2 expression was regulated by ERK1/2 activation. Synovial fibroblasts were pretreated with U0126, a MEK1/2 inhibitor, at a concentration of 20 muM for 2 h before addition of C. albicans (2 x 105 yeasts/dish for 12 h) (Figure 3a). C. albicans increased ERK1/2 phosphorylation and COX-2 expression in the absence but not the presence of U0126. U0126 by itself had no effect on COX-2 expression or ERK1/2 phosphorylation. MG132 as an NFkappaB inhibitor suppressed the COX-2 expression (Figure 3b). Immunohistochemistry (Figure 4) demonstrates increased phospho-ERK1/2 and COX-2 expression in synovial fibroblasts to which C. albicans are adherent. However, the cells without C. albicans attachment demonstrated only very weak positivity. In the presence of U0126 no expression of phospho-ERK1/2 or COX-2 is demonstrable in the infected synovial fibroblasts.
###end p 40
###begin p 41
###xml 188 204 180 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 270 272 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 314 318 306 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 383 387 375 379 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 754 756 740 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
###xml 756 758 742 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 188 204 <span type="species:ncbi:5476">Candida albicans</span>
###xml 272 278 <span type="species:ncbi:4932">yeasts</span>
The effect of extracellular-regulated kinase (ERK) and nuclear factor kappaB (NFkappaB) inhibition on cyclo-oxygenase 2 (COX-2) production following infection of synovial fibroblasts with Candida albicans. Following infection of synovial fibroblasts for 12 h with 2 x 105 yeasts/dish in the absence or presence of (a) the mitogen-activated protein kinase (MEK)1/2 inhibitor U0126 or (b) the NFkappaB inhibitor MG-132 COX-2 protein levels were assessed by western blotting. Shown is a representative blots from N = 3 experiments. The graphs shows the results of densitometric analysis of bands expressed as the mean +/- standard deviation (SD) of the relative fold change in band density with the ratio of the control condition normalized to 1 (N = 3, *, # P < 0.05).
###end p 41
###begin p 42
###xml 159 176 159 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 221 233 221 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 389 393 389 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 441 445 441 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 475 479 475 479 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 514 525 514 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 527 531 527 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 566 578 566 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 159 175 <span type="species:ncbi:5476">Candida albicans</span>
###xml 221 232 <span type="species:ncbi:5476">C. albicans</span>
###xml 514 525 <span type="species:ncbi:5476">C. albicans</span>
###xml 566 577 <span type="species:ncbi:5476">C. albicans</span>
Immunocytochemical detection of cyclo-oxygenase 2 (COX-2) and phospho-extracellular-regulated kinase (ERK)1/2 expression in synovial fibroblasts infected with Candida albicans for 12 h. Synovial fibroblasts infected with C. albicans in the absence (c) or presence (d) of the mitogen-activated protein kinase (MEK)1/2 inhibitor U0126 were immunostained for COX-2 and phosphorylated ERK1/2. (a) Negative control with omitted primary antibody. (b) Control synovial fibroblasts. (c) Synovial fibroblasts infected with C. albicans. (d) Synovial fibroblasts infected with C. albicans in the presence of U0126 (insert x 1,000; others x 400).
###end p 42
###begin title 43
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
PGE2 production
###end title 43
###begin p 44
###xml 117 119 117 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 187 199 187 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 212 214 212 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 299 311 299 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 187 198 <span type="species:ncbi:5476">C. albicans</span>
###xml 299 310 <span type="species:ncbi:5476">C. albicans</span>
To assess whether increased expression of COX-2 was associated with changes in prostaglandin production levels of PGE2 released into the media was measured (Figure 5). In the presence of C. albicans infection PGE2 release into the media was significantly increased over basal levels. This effect of C. albicans was suppressed by the addition of U0126.
###end p 44
###begin p 45
###xml 14 31 14 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 144 156 144 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 162 164 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 330 332 330 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 360 372 360 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 409 411 409 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 419 431 419 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 442 454 442 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 462 464 462 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 14 30 <span type="species:ncbi:5476">Candida albicans</span>
###xml 144 155 <span type="species:ncbi:5476">C. albicans</span>
###xml 164 170 <span type="species:ncbi:4932">yeasts</span>
###xml 360 371 <span type="species:ncbi:5476">C. albicans</span>
###xml 419 430 <span type="species:ncbi:5476">C. albicans</span>
###xml 442 453 <span type="species:ncbi:5476">C. albicans</span>
The effect of Candida albicans infection of prostaglandin E2 (PGE2) production by synovial fibroblasts. Synovial fibroblasts were infected with C. albicans 2 x 105 yeasts/dish for 12 h in the absence or presence of mitogen-activated protein kinase (MEK1)/2 inhibitor U0126 and the supernatants were collected for assessment of PGE2 production by ELISA. N = 5, C. albicans vs phosphate-buffered saline (PBS), *P < 0.05; C. albicans + U0126 vs C. albicans alone, #P < 0.05.
###end p 45
###begin title 46
Laminarin effect and trans-well experiment
###end title 46
###begin p 47
###xml 131 143 131 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 270 281 270 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 322 334 322 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 398 400 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 490 492 488 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 579 590 577 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 681 683 679 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 714 726 712 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 752 764 750 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 785 787 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 871 873 867 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 889 891 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 923 935 919 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1147 1158 1143 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 131 142 <span type="species:ncbi:5476">C. albicans</span>
###xml 270 281 <span type="species:ncbi:5476">C. albicans</span>
###xml 322 333 <span type="species:ncbi:5476">C. albicans</span>
###xml 579 590 <span type="species:ncbi:5476">C. albicans</span>
###xml 714 725 <span type="species:ncbi:5476">C. albicans</span>
###xml 752 763 <span type="species:ncbi:5476">C. albicans</span>
###xml 923 934 <span type="species:ncbi:5476">C. albicans</span>
###xml 1147 1158 <span type="species:ncbi:5476">C. albicans</span>
To assess whether COX-2 induction was dependent on interactions with the dectin-1 receptor synovial fibroblasts were infected with C. albicans in the presence of laminarin (Figure 6). Laminarin had no effect on levels of synovial fibroblast COX-2 mRNA in the absence of C. albicans. Infection of synovial fibroblasts with C. albicans resulted in a 2 +/- 0.3-fold increase in COX-2 gene expression (P < 0.05). In the presence of laminarin there was a lower, 1.6 + 0.3-fold, but significant (P < 0.05) increase in COX-2 gene expression when synovial fibroblasts were infected with C. albicans. This 20% decrease in COX-2 gene expression by laminarin was statistically significantly (P < 0.05, synovial fibroblasts + C. albicans vs synovial fibroblasts + C. albicans + laminarin) (Figure 6a). COX-2 gene expression was significantly upregulated (1.71 +/- 0.3-fold increase, P < 0.05) (Figure 6b) when synovial fibroblasts and C. albicans were co-cultured in different trans-well chambers. This indicates that direct contact may have only a minor contribution to the elevation of COX-2 gene expression seen when synovial fibroblasts are infected with C. albicans.
###end p 47
###begin p 48
###xml 167 183 167 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 185 189 185 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 229 241 229 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 345 357 345 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 418 420 418 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 427 439 427 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 557 559 557 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 578 590 578 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 593 605 593 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 613 617 613 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 642 654 642 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 854 866 854 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 933 945 933 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1021 1033 1021 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1087 1099 1087 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1147 1159 1147 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1246 1248 1246 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 167 183 <span type="species:ncbi:5476">Candida albicans</span>
###xml 229 240 <span type="species:ncbi:5476">C. albicans</span>
###xml 345 356 <span type="species:ncbi:5476">C. albicans</span>
###xml 427 438 <span type="species:ncbi:5476">C. albicans</span>
###xml 578 589 <span type="species:ncbi:5476">C. albicans</span>
###xml 593 604 <span type="species:ncbi:5476">C. albicans</span>
###xml 642 653 <span type="species:ncbi:5476">C. albicans</span>
###xml 854 865 <span type="species:ncbi:5476">C. albicans</span>
###xml 933 944 <span type="species:ncbi:5476">C. albicans</span>
###xml 1021 1032 <span type="species:ncbi:5476">C. albicans</span>
###xml 1087 1098 <span type="species:ncbi:5476">C. albicans</span>
###xml 1147 1158 <span type="species:ncbi:5476">C. albicans</span>
Requirement for dectin-1 and cell-cell interactions in upregulation of cyclo-oxygenase 2 (COX-2) expression (measured by RT-PCR) in synovial fibroblasts infected with Candida albicans. (a) Synovial fibroblasts were infected with C. albicans in the absence or presence of 10 mg/ml laminarin and COX-2 gene expression assessed. In the presence of C. albicans COX-2 gene expression by synovial fibroblasts is increased (*P < 0.05 C. albicans vs phosphate-buffered saline (PBS)). This increase in COX-2 gene expression is decreased by around 20% by laminarin (#P < 0.05 laminarin + C. albicans vs C. albicans alone). (b) Synovial fibroblasts and C. albicans were seeded in different chambers of trans-well plates overnight followed by 12 h of chamber interaction and subsequent assessment of COX-2 gene expression in synovial fibroblasts (lanes 1 and 2) and C. albicans (lane 3). Lane 1: synovial fibroblasts in the upper chamber and no C. albicans in the lower chamber. Lane 2: synovial fibroblasts in the upper chamber and C. albicans in the lower chamber. Lane 3: empty upper chamber and C. albicans in the lower chamber. RT-PCR using the RNA from C. albicans showed no band of COX-2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (N = 5, * P < 0.05).
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 131 143 131 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 131 142 <span type="species:ncbi:5476">C. albicans</span>
The present study has demonstrated that synovial fibroblast expression of COX-2, under the control of ERK1/2, is induced following C. albicans infection. Upregulation of COX-2 is associated with NFkappaB activation and appears to be more prominent in synovial fibroblasts adjacent to fungal colonies.
###end p 50
###begin p 51
###xml 86 98 86 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 149 161 149 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 217 229 217 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 328 340 324 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 358 360 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 414 416 410 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 463 475 459 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 476 478 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 481 493 477 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 586 588 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 669 671 665 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 86 97 <span type="species:ncbi:5476">C. albicans</span>
###xml 149 160 <span type="species:ncbi:5476">C. albicans</span>
###xml 217 228 <span type="species:ncbi:5476">C. albicans</span>
###xml 328 339 <span type="species:ncbi:5476">C. albicans</span>
###xml 430 435 <span type="species:ncbi:10090">mouse</span>
###xml 463 474 <span type="species:ncbi:5476">C. albicans</span>
###xml 481 492 <span type="species:ncbi:5476">C. albicans</span>
The finding that ERK1/2 phosphorylation occurs on exposure of synovial fibroblasts to C. albicans is consistent with observations of interactions of C. albicans with inflammatory and epithelial cells. Phagocytosis of C. albicans by macrophages results in ERK phosphorylation [29] and TNFalpha production by monocytes exposed to C. albicans is ERK dependent [32]. TLR2 appears to be the major receptor mediating PGE2 production by mouse macrophages in response to C. albicans [28]. C. albicans increases COX-2 expression in HeLa cells with roles for both TLR2 and TLR4 being identified [25]. Similar mechanisms are likely to be involved in the induction of COX-2 and PGE2 production in the current study.
###end p 51
###begin p 52
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 407 419 407 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 757 759 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 852 854 846 848 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 887 889 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1023 1035 1017 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1137 1148 1131 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 1191 1193 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1218 1230 1212 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1360 1362 1351 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 407 418 <span type="species:ncbi:5476">C. albicans</span>
###xml 709 715 <span type="species:ncbi:10090">murine</span>
###xml 732 737 <span type="species:ncbi:9606">human</span>
###xml 868 873 <span type="species:ncbi:9606">human</span>
###xml 1023 1034 <span type="species:ncbi:5476">C. albicans</span>
###xml 1137 1148 <span type="species:ncbi:5476">C. albicans</span>
###xml 1218 1229 <span type="species:ncbi:5476">C. albicans</span>
Toll-like receptors have been shown to be involved in synovial inflammation in a wide range of inflammatory joint diseases including rheumatoid arthritis [34,35], Lyme arthritis [36], and streptococcal cell wall-induced arthritis [37]. TLR signaling is also likely to be involved in mediating proinflammatory responses and subsequent tissue destruction in fungal arthritis. The basic cell wall structure of C. albicans consists of a linear beta-glucan backbone from which there are covalently attached branches of additional beta-glucan and mannoproteins. Mannoproteins, highly antigenic proteins with large numbers of mannose groups attached have been shown to induce pro-inflammatory cytokine production in murine macrophages and human mononuclear cells [38]. Mannose-containing molecular patterns are also strong inducers of COX-2 expression and PGE2 production in human macrophages [39]. TLR have important roles in the induction of cytokines by fungi with TLR4 recognition of O-linked mannosyl residues present in the C. albicans cell wall are thought to be particularly important. Phospholipomannan, present in the cell surface of C. albicans, has been shown to be recognized by TLR2 [40]. Cytokine induction by C. albicans may also be through recognition of beta-glucan by the dectin-1 (dentritic cell-associated C-type lectin-1)/TLR2 receptor complex [38].
###end p 52
###begin p 53
###xml 265 267 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 330 332 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 406 408 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 493 505 486 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 516 518 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 654 665 647 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 822 834 815 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 992 1004 985 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 270 273 <span type="species:ncbi:10116">Rat</span>
###xml 493 504 <span type="species:ncbi:5476">C. albicans</span>
###xml 654 665 <span type="species:ncbi:5476">C. albicans</span>
###xml 822 833 <span type="species:ncbi:5476">C. albicans</span>
###xml 992 1003 <span type="species:ncbi:5476">C. albicans</span>
Dectin-1, a major beta-glucan receptor, has a number of antimicrobial functions in phagocytes including induction of cytokines and chemokines, possibly by collaborating with TLRs, involvement in endocytosis and phagocytosis and production of the respiratory burst [33]. Rat dectin-1 is involved in immune responses against fungi [41]. Laminarin, a soluble form of glucan blocks signaling through dectin-1 [42]. Laminarin decreases TNFalpha production by macrophages in response to zymosan and C. albicans infection [43]. In the current study laminarin partially blocked the increase in COX-2 mRNA that is seen when synovial fibroblasts are infected with C. albicans. This indicates that signaling through dectin-1 has a partial role in the upregulation of COX-2 gene expression. This may be through direct contact between C. albicans and synovial fibroblasts as the elevation of COX-2 gene expression was similar in trans-well experiments and experiments with laminarin where contact between C. albicans and synovial fibroblasts was possible.
###end p 53
###begin title 54
Conclusions
###end title 54
###begin p 55
###xml 55 57 55 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 98 110 98 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 375 387 371 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 98 109 <span type="species:ncbi:5476">C. albicans</span>
###xml 375 386 <span type="species:ncbi:5476">C. albicans</span>
We show for the first time that COX-2 induction and PGE2 production occurs following infection of C. albicans to synovial fibroblasts and that this requires ERK1/2 activation and is associated with NFkappaB activation. These interactions may significantly contribute to the detrimental inflammatory/catabolic activities of synovial fibroblasts in septic arthritis induced by C. albicans and other fungi.
###end p 55
###begin title 56
Abbreviations
###end title 56
###begin p 57
###xml 478 479 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 496 497 488 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 36 42 <span type="species:ncbi:9913">bovine</span>
###xml 300 311 <span type="species:ncbi:3704">horseradish</span>
AEC: 3-amino-9-ethylcarbazole; BSA: bovine serum albumin; COX-2: cyclo-oxygenase 2; EDTA: ethylenediaminetetraacetic acid; ELISA: enzyme-linked immunosorbent assay; EMSA: electrophoretic-mobility shift assay; ERK: extracellular-regulated kinase; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HRP: horseradish peroxidase; IL: interleukin; JNK: c-Jun N-terminal kinase; MEK: mitogen-activated protein kinase; NFkappaB: nuclear factor kappaB; PBS: phosphate-buffered saline; PGE2: prostaglandin E2; PKC: protein kinase C; PVDF: polyvinylidene difluoride; RT-PCR: reverse transcription polymerase chain reaction; SD: Sprague-Dawley; TBST: Tris-buffered saline/Tween; TLR: Toll-like receptor; TNF: tumor necrosis factor.
###end p 57
###begin title 58
Competing interests
###end title 58
###begin p 59
The authors declare that they have no competing interests.
###end p 59
###begin title 60
Authors' contributions
###end title 60
###begin p 61
HSL conceived of the study, participated in its design and coordination, participated in the interpretation of results, and predominantly drafted the manuscript. CSL supervised the experiments by CJY. CJY carried out the RT-PCR, western blotting, EMSA, immunocytochemistry, and ELISA. SLS performed the statistical analysis. DMS helped to discuss the results and draft the manuscript. All authors read and approved the final manuscript.
###end p 61
###begin title 62
Acknowledgements
###end title 62
###begin p 63
This study was supported by a grant from the National Science Council and National Defense Medical Center, Tri-Service General Hospital, Taiwan (NSC95-2320-B-016-018-MY2, NSC97-2320-B-016-009-MY3, DOD96-13-03 and DOD97-08-06).
###end p 63
###begin article-title 64
###xml 119 135 114 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Grifola frondosa</italic>
###xml 119 135 <span type="species:ncbi:5627">Grifola frondosa</span>
Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa
###end article-title 64
###begin article-title 65
Candida osteomyelitis. Report of five cases and review of the literature
###end article-title 65
###begin article-title 66
###xml 39 46 <span type="species:ncbi:9606">patient</span>
Candidal prosthetic hip infection in a patient with previous candidal septic arthritis
###end article-title 66
###begin article-title 67
Fungal arthritis and osteomyelitis
###end article-title 67
###begin article-title 68
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
Fungal arthritis. I. Candida arthritis: diagnostic and prognostic implications and therapeutic considerations
###end article-title 68
###begin article-title 69
###xml 9 17 9 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome
###end article-title 69
###begin article-title 70
###xml 38 57 38 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida tropicalis </italic>
###xml 38 56 <span type="species:ncbi:5482">Candida tropicalis</span>
###xml 97 104 <span type="species:ncbi:9606">patient</span>
Septic arthritis as the first sign of Candida tropicalis fungaemia in an acute lymphoid leukemia patient
###end article-title 70
###begin article-title 71
Neonatal and infantile candidal arthritis with or without osteomyelitis: a clinical and radiographical review of 21 cases
###end article-title 71
###begin article-title 72
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 47 51 <span type="species:ncbi:10116">rats</span>
Induction of experimental Candida arthritis in rats
###end article-title 72
###begin article-title 73
###xml 54 70 54 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 54 70 <span type="species:ncbi:5476">Candida albicans</span>
Inflammation induced by inoculation of the joint with Candida albicans
###end article-title 73
###begin article-title 74
###xml 35 52 32 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 35 51 <span type="species:ncbi:5476">Candida albicans</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Cell wall beta-glucan derived from Candida albicans acts as a trigger for autoimmune arthritis in SKG mice
###end article-title 74
###begin article-title 75
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis
###end article-title 75
###begin article-title 76
The role of cytokines in osteoarthritis pathophysiology
###end article-title 76
###begin article-title 77
###xml 167 172 <span type="species:ncbi:9606">human</span>
Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts
###end article-title 77
###begin article-title 78
The IL-1 family and inflammatory diseases
###end article-title 78
###begin article-title 79
The role of COX-2 in angiogenesis and rheumatoid arthritis
###end article-title 79
###begin article-title 80
###xml 151 156 <span type="species:ncbi:9606">human</span>
Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci
###end article-title 80
###begin article-title 81
###xml 112 120 <span type="species:ncbi:9606">patients</span>
Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis
###end article-title 81
###begin article-title 82
Clinical manifestations of gout and their management
###end article-title 82
###begin article-title 83
###xml 119 122 <span type="species:ncbi:10116">rat</span>
Prophylactic effect of highly selective COX-2 inhibition in acute monosodium urate crystal induced inflammation in the rat subcutaneous air pouch
###end article-title 83
###begin article-title 84
Cyclooxygenase-2 and prostaglandins in articular tissues
###end article-title 84
###begin article-title 85
Chondroprotective effect of salicylate and chloroquine in pyogenic septic arthritis
###end article-title 85
###begin article-title 86
###xml 36 44 <span type="species:ncbi:136217">turmeric</span>
Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis
###end article-title 86
###begin article-title 87
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 115 119 <span type="species:ncbi:10116">rats</span>
In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
###end article-title 87
###begin article-title 88
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 0 16 <span type="species:ncbi:5476">Candida albicans</span>
Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B
###end article-title 88
###begin article-title 89
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 0 16 <span type="species:ncbi:5476">Candida albicans</span>
Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells
###end article-title 89
###begin article-title 90
Regulation of cytosolic phospholipase A2 activation and cyclooxygenase 2 expression in macrophages by the beta-glucan receptor
###end article-title 90
###begin article-title 91
###xml 124 140 124 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 63 69 <span type="species:ncbi:10090">murine</span>
###xml 124 140 <span type="species:ncbi:5476">Candida albicans</span>
Toll-like receptor 2 mediates prostaglandin E(2) production in murine peritoneal macrophages and splenocytes in response to Candida albicans
###end article-title 91
###begin article-title 92
###xml 87 103 87 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 87 103 <span type="species:ncbi:5476">Candida albicans</span>
Role of extracellular signal-regulated protein kinase cascade in macrophage killing of Candida albicans
###end article-title 92
###begin article-title 93
###xml 121 137 121 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 121 137 <span type="species:ncbi:5476">Candida albicans</span>
Impairment of p38 MAPK-mediated cytosolic phospholipase A2 activation in the kidneys is associated with pathogenicity of Candida albicans
###end article-title 93
###begin article-title 94
###xml 53 70 53 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 53 69 <span type="species:ncbi:5476">Candida albicans</span>
Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase
###end article-title 94
###begin article-title 95
###xml 22 39 22 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 22 38 <span type="species:ncbi:5476">Candida albicans</span>
Monocyte responses to Candida albicans are enhanced by antibody in cooperation with antibody-independent pathogen recognition
###end article-title 95
###begin article-title 96
beta-Glucans and dectin-1
###end article-title 96
###begin article-title 97
Increased macrophage activation mediated through Toll-like receptors in rheumatoid arthritis
###end article-title 97
###begin article-title 98
###xml 122 127 <span type="species:ncbi:9606">human</span>
The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis
###end article-title 98
###begin article-title 99
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease
###end article-title 99
###begin article-title 100
Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88
###end article-title 100
###begin article-title 101
###xml 18 35 18 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 18 34 <span type="species:ncbi:5476">Candida albicans</span>
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors
###end article-title 101
###begin article-title 102
###xml 124 129 <span type="species:ncbi:9606">human</span>
Mannose-containing molecular patterns are strong inducers of cyclooxygenase-2 expression and prostaglandin E2 production in human macrophages
###end article-title 102
###begin article-title 103
Toll-like receptors as key mediators in innate antifungal immunity
###end article-title 103
###begin article-title 104
###xml 20 23 <span type="species:ncbi:10116">rat</span>
Characterization of rat beta-glucan receptor dectin-1
###end article-title 104
###begin article-title 105
Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2
###end article-title 105
###begin article-title 106
###xml 41 58 41 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 41 57 <span type="species:ncbi:5476">Candida albicans</span>
###xml 78 84 <span type="species:ncbi:10090">murine</span>
Enhanced proinflammatory response to the Candida albicans gpi7 null mutant by murine cells
###end article-title 106

